Glycerol phenylbutyrate and Recombinate
Determining the interaction of Glycerol phenylbutyrate and Recombinate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycerol phenylbutyrate
Brand name: Ravicti
Synonyms: n.a.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Recombinate (recombinant)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycerol phenylbutyrate-Recombinate recombinant
- Glycerol phenylbutyrate-Recombivax
- Glycerol phenylbutyrate-Recombivax HB
- Glycerol phenylbutyrate-Recombivax HB Adult
- Glycerol phenylbutyrate-Recombivax HB Dialysis Formulation
- Glycerol phenylbutyrate-Recombivax HB Pediatric/Adolescent
- Recombinate-GlycoLax
- Recombinate-Glycophos
- Recombinate-Glycophos Injection
- Recombinate-Glycopyrrolate
- Recombinate-Glycopyrrolate (Oral Inhalation)
- Recombinate-Glycopyrrolate (Systemic)